Drug Information Association Logo

Prominent Regulatory Experts to Speak at DIA’s Special Symposium after PMDA Forum

TOKYO, JAPAN — Jan 21, 2014

High profile representatives from the Pharmaceuticals and Medical Devices Agency (PMDA), the European Medicines Agency (EMA), the World Health Organization (WHO) and regulatory authorities around the world are to speak at DIA Japan’s Special Symposium, to be held in Tokyo following the PMDA Forum.

This year's PMDA Forum, to be held on February 8, will commemorate the organization’s 10th anniversary. DIA Japan, supported by the PMDA, has invited high profile speakers who will attend the forum to present at a Special Symposium at Sola City Hall on the following day, February 9.

The symposium will focus on the question of how innovative products can be delivered expeditiously to patients worldwide, and will highlight the role of regulatory authorities and industry. Attendees will enjoy open discussion with speakers from around the world on topics such as global policies and the environment for innovative drug development from political, regulatory, social, scientific and technological perspectives, with the aim of contributing to future global health.

High profile speakers will include:

  • Guido Rasi, MD, Executive Director, EMA
  • Tatsuya Kondo, MD, PhD, Chief Executive, PMDA
  • Masafumi Nogimori, Vice President, Japan Pharmaceutical Manufacturers Association (JPMA)
  • John C.W. Lim, MD, Chief Executive Officer, Health Sciences Authority (HSA)
  • Kees de Joncheere, MPharm, MBA, Director of Essential Medicines and Health Products, World Health Organization (WHO)
  • Haruo Naito, President, Federation of Pharmaceutical Manufacturers’ Associations of Japan
To attend, download and complete the registration form at www.diahome.org/specialsymposium and send it to DIA Japan (fax: +81.3.3583.1200 or email: diajapan@diajapan.org) by January 31. For more information email diajapan@diajapan.org.

Contact: Keiko Cambridge
Event Planning Manager



ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.